Acadia Receives FDA Priority Review For Parkinson's Drug
November 03, 2015 at 12:25 PM EST
Acadia receives FDA Priority Review for Parkinson's Drug; Shares closed up 15% yesterday.
|
||||||||||||
|
||||||||||||
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map |